Omega Diagnostics Group (LON:ODX) had its price target trimmed by FinnCap from GBX 30 ($0.40) to GBX 27 ($0.36) in a report published on Thursday. The brokerage currently has a corporate rating on the stock.

Shares of Omega Diagnostics Group (ODX) opened at GBX 17.13 ($0.23) on Thursday. Omega Diagnostics Group has a 12 month low of GBX 15.35 ($0.21) and a 12 month high of GBX 28.01 ($0.38).

TRADEMARK VIOLATION WARNING: This report was originally published by Watch List News and is the sole property of of Watch List News. If you are reading this report on another domain, it was copied illegally and reposted in violation of international trademark & copyright laws. The correct version of this report can be read at https://www.watchlistnews.com/omega-diagnostics-group-odx-given-new-gbx-27-price-target-at-finncap/1771215.html.

Omega Diagnostics Group Company Profile

Omega Diagnostics Group PLC is a medical diagnostics company. The Company’s segments are Allergy and Autoimmune; Food Intolerance; Infectious/Other, and Corporate. Its product categories include allergy, anemia, autoimmunity, fertility and growth hormones, food intolerance, infectious disease, inflammation, quality control, thyroid hormones and tumor markers.

Receive News & Ratings for Omega Diagnostics Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Omega Diagnostics Group and related companies with MarketBeat.com's FREE daily email newsletter.